Ovarian Cancer

Optimal dose suggested for dasatinib in ovarian cancer

(HealthDay)—A phase I trial of dasatinib combined with paclitaxel and carboplatin has determined the optimal dose of dasatinib and suggested some efficacy in women with advanced or recurrent ovarian cancer, ...

Nov 19, 2012
popularity 5 / 5 (1) | comments 0

Two-step immunotherapy attacks advanced ovarian cancer

Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine ...

Jan 31, 2013
popularity 5 / 5 (1) | comments 0

Ovarian cancer risk reduced by prolonged lactation

Curtin University researchers have found that women who breastfeed their babies have significantly reduced rates of ovarian cancer in a study that extends what was known about the beneficial effects of breastfeeding on mothers.

Feb 01, 2013
popularity 5 / 5 (1) | comments 0

Origin of aggressive ovarian cancer discovered

Cornell University researchers have discovered a likely origin of epithelial ovarian cancer (ovarian carcinoma), the fifth leading cause of cancer death among women in the United States.

Mar 06, 2013
popularity 5 / 5 (1) | comments 0 | with audio podcast

Latest Spotlight News

Wine only protects against CVD in people who exercise

Wine only protects against cardiovascular disease (CVD) in people who exercise, according to results from the In Vino Veritas (IVV) study presented at ESC Congress today by Professor Milos Taborsky from the ...